vs
iRhythm Holdings, Inc.（IRTC）与3M（MMM）财务数据对比。点击上方公司名可切换其他公司
3M的季度营收约是iRhythm Holdings, Inc.的28.9倍（$6.0B vs $208.9M）。3M净利率更高（10.8% vs 2.7%，领先8.2%）。iRhythm Holdings, Inc.同比增速更快（27.1% vs 1.3%）。3M自由现金流更多（$2.0B vs $14.5M）。过去两年iRhythm Holdings, Inc.的营收复合增速更高（25.8% vs -1.8%）
iRhythm Holdings是一家专注于心脏护理领域的数字医疗企业，开发可穿戴动态心脏监测设备及配套AI分析工具，主要服务美国市场的医疗机构与患者，帮助检测房颤等心律异常病症，为临床诊断提供可靠的数据支持。
3M是美国知名跨国综合企业，业务覆盖工业、劳动者安全防护、消费品等多个领域，总部位于圣保罗郊区的枫木市。公司现有超6万款产品，涵盖胶粘剂、研磨材料、防火防护产品、个人防护装备、窗膜、车漆保护膜、电子连接绝缘材料、汽车养护产品、光学膜等品类。
IRTC vs MMM — 直观对比
营收规模更大
MMM
是对方的28.9倍
$208.9M
营收增速更快
IRTC
高出25.8%
1.3%
净利率更高
MMM
高出8.2%
2.7%
自由现金流更多
MMM
多$2.0B
$14.5M
两年增速更快
IRTC
近两年复合增速
-1.8%
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $208.9M | $6.0B |
| 净利润 | $5.6M | $653.0M |
| 毛利率 | 70.9% | 40.7% |
| 营业利润率 | 1.1% | 23.2% |
| 净利率 | 2.7% | 10.8% |
| 营收同比 | 27.1% | 1.3% |
| 净利润同比 | 518.5% | -41.5% |
| 每股收益（稀释后） | $0.18 | $1.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRTCMMM
| Q1 26 | — | $6.0B | ||
| Q4 25 | $208.9M | $6.1B | ||
| Q3 25 | $192.9M | $6.5B | ||
| Q2 25 | $186.7M | $6.3B | ||
| Q1 25 | $158.7M | $6.0B | ||
| Q4 24 | $164.3M | $6.0B | ||
| Q3 24 | $147.5M | $6.3B | ||
| Q2 24 | $148.0M | $6.3B |
净利润IRTCMMM
| Q1 26 | — | $653.0M | ||
| Q4 25 | $5.6M | $577.0M | ||
| Q3 25 | $-5.2M | $834.0M | ||
| Q2 25 | $-14.2M | $723.0M | ||
| Q1 25 | $-30.7M | $1.1B | ||
| Q4 24 | $-1.3M | $728.0M | ||
| Q3 24 | $-46.2M | $1.4B | ||
| Q2 24 | $-20.1M | $1.1B |
毛利率IRTCMMM
| Q1 26 | — | 40.7% | ||
| Q4 25 | 70.9% | 33.6% | ||
| Q3 25 | 71.1% | 41.8% | ||
| Q2 25 | 71.2% | 42.5% | ||
| Q1 25 | 68.8% | 41.6% | ||
| Q4 24 | 70.0% | 51.7% | ||
| Q3 24 | 68.8% | 42.1% | ||
| Q2 24 | 69.9% | 42.9% |
营业利润率IRTCMMM
| Q1 26 | — | 23.2% | ||
| Q4 25 | 1.1% | 13.0% | ||
| Q3 25 | -4.4% | 22.2% | ||
| Q2 25 | -10.0% | 18.0% | ||
| Q1 25 | -20.5% | 20.9% | ||
| Q4 24 | -2.5% | 12.2% | ||
| Q3 24 | -34.1% | 20.9% | ||
| Q2 24 | -15.5% | 20.3% |
净利率IRTCMMM
| Q1 26 | — | 10.8% | ||
| Q4 25 | 2.7% | 9.4% | ||
| Q3 25 | -2.7% | 12.8% | ||
| Q2 25 | -7.6% | 11.4% | ||
| Q1 25 | -19.3% | 18.7% | ||
| Q4 24 | -0.8% | 12.1% | ||
| Q3 24 | -31.3% | 21.8% | ||
| Q2 24 | -13.6% | 18.3% |
每股收益（稀释后）IRTCMMM
| Q1 26 | — | $1.23 | ||
| Q4 25 | $0.18 | $1.07 | ||
| Q3 25 | $-0.16 | $1.55 | ||
| Q2 25 | $-0.44 | $1.34 | ||
| Q1 25 | $-0.97 | $2.04 | ||
| Q4 24 | $-0.03 | $1.33 | ||
| Q3 24 | $-1.48 | $2.48 | ||
| Q2 24 | $-0.65 | $2.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $583.8M | $3.7B |
| 总债务越低越好 | — | $10.9B |
| 股东权益账面价值 | $152.7M | $3.3B |
| 总资产 | $1.0B | $35.4B |
| 负债/权益比越低杠杆越低 | — | 3.29× |
8季度趋势，按日历期对齐
现金及短期投资IRTCMMM
| Q1 26 | — | $3.7B | ||
| Q4 25 | $583.8M | — | ||
| Q3 25 | $565.2M | — | ||
| Q2 25 | $545.5M | — | ||
| Q1 25 | $520.6M | — | ||
| Q4 24 | $535.6M | — | ||
| Q3 24 | $522.0M | — | ||
| Q2 24 | $561.5M | — |
总债务IRTCMMM
| Q1 26 | — | $10.9B | ||
| Q4 25 | — | $12.6B | ||
| Q3 25 | — | $12.6B | ||
| Q2 25 | — | $13.1B | ||
| Q1 25 | — | $13.5B | ||
| Q4 24 | — | $13.0B | ||
| Q3 24 | — | $13.2B | ||
| Q2 24 | — | $13.1B |
股东权益IRTCMMM
| Q1 26 | — | $3.3B | ||
| Q4 25 | $152.7M | $4.7B | ||
| Q3 25 | $121.9M | $4.6B | ||
| Q2 25 | $103.7M | $4.3B | ||
| Q1 25 | $86.7M | $4.5B | ||
| Q4 24 | $90.9M | $3.8B | ||
| Q3 24 | $71.8M | $4.6B | ||
| Q2 24 | $99.2M | $3.9B |
总资产IRTCMMM
| Q1 26 | — | $35.4B | ||
| Q4 25 | $1.0B | $37.7B | ||
| Q3 25 | $995.2M | $37.6B | ||
| Q2 25 | $964.0M | $38.0B | ||
| Q1 25 | $926.1M | $40.0B | ||
| Q4 24 | $931.4M | $39.9B | ||
| Q3 24 | $909.7M | $40.9B | ||
| Q2 24 | $919.2M | $43.4B |
负债/权益比IRTCMMM
| Q1 26 | — | 3.29× | ||
| Q4 25 | — | 2.68× | ||
| Q3 25 | — | 2.72× | ||
| Q2 25 | — | 3.06× | ||
| Q1 25 | — | 3.02× | ||
| Q4 24 | — | 3.40× | ||
| Q3 24 | — | 2.84× | ||
| Q2 24 | — | 3.34× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.2M | — |
| 自由现金流经营现金流 - 资本支出 | $14.5M | $2.0B |
| 自由现金流率自由现金流/营收 | 6.9% | 33.6% |
| 资本支出强度资本支出/营收 | 5.6% | — |
| 现金转化率经营现金流/净利润 | 4.70× | — |
| 过去12个月自由现金流最近4个季度 | $34.5M | $3.7B |
8季度趋势，按日历期对齐
经营现金流IRTCMMM
| Q1 26 | — | — | ||
| Q4 25 | $26.2M | $1.6B | ||
| Q3 25 | $34.9M | $1.8B | ||
| Q2 25 | $27.7M | $-954.0M | ||
| Q1 25 | $-7.9M | $-79.0M | ||
| Q4 24 | $19.2M | $1.8B | ||
| Q3 24 | $24.3M | $-1.8B | ||
| Q2 24 | $11.8M | $1.0B |
自由现金流IRTCMMM
| Q1 26 | — | $2.0B | ||
| Q4 25 | $14.5M | $1.3B | ||
| Q3 25 | $20.1M | $1.5B | ||
| Q2 25 | $17.3M | $-1.2B | ||
| Q1 25 | $-17.3M | $-315.0M | ||
| Q4 24 | $12.4M | $1.5B | ||
| Q3 24 | $15.5M | $-2.0B | ||
| Q2 24 | $3.4M | $752.0M |
自由现金流率IRTCMMM
| Q1 26 | — | 33.6% | ||
| Q4 25 | 6.9% | 21.8% | ||
| Q3 25 | 10.4% | 23.6% | ||
| Q2 25 | 9.3% | -18.3% | ||
| Q1 25 | -10.9% | -5.3% | ||
| Q4 24 | 7.5% | 25.4% | ||
| Q3 24 | 10.5% | -32.3% | ||
| Q2 24 | 2.3% | 12.0% |
资本支出强度IRTCMMM
| Q1 26 | — | — | ||
| Q4 25 | 5.6% | 4.0% | ||
| Q3 25 | 7.7% | 3.3% | ||
| Q2 25 | 5.6% | 3.3% | ||
| Q1 25 | 5.9% | 4.0% | ||
| Q4 24 | 4.2% | 4.8% | ||
| Q3 24 | 6.0% | 3.9% | ||
| Q2 24 | 5.7% | 4.3% |
现金转化率IRTCMMM
| Q1 26 | — | — | ||
| Q4 25 | 4.70× | 2.74× | ||
| Q3 25 | — | 2.11× | ||
| Q2 25 | — | -1.32× | ||
| Q1 25 | — | -0.07× | ||
| Q4 24 | — | 2.50× | ||
| Q3 24 | — | -1.30× | ||
| Q2 24 | — | 0.89× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
MMM
| Safety and Industrial business segment | $2.9B | 49% |
| Transportation and Electronics business segment | $1.8B | 31% |
| Consumer business segment | $1.1B | 19% |
| Corporate | $121.0M | 2% |
